Therapeutic Comparative Trial for Bipolar Disorders Medication - Essay Example

Bipolar disorder is clear episode of mania or hypomania and also other types of mental conditions that can result from depression or mood swings. The brain disorders that alter individual mood, strength, and aptitude to work. It's a condition that as three status for the health like the bipolar I, bipolar II and cyclothymic condition. Does one of the mood disorders that affect a small group within a population.

Bipolar I effect can bring numerous manic conditions or mixed like manic and depressive. This health status at the time leads to a depressive episode in some individuals with the situation.

Bipolar II disorder has one or several severe depressive episodes with at least one hypomanic episode. No manic status, but the one may experience mixed moods. It disrupts one's ability to work as bipolar I disorder. Signs of distress at work, closeness or learning institutions. Persons with this condition do not recall their hypomanic disorder.

Clinical information about the condition, affected ones, and the research institutions should support the health.

The categories for this can include clinical information about the disorders, persons who are affected by it, and organizations involved in researching and advocating about bipolar disorder.

Anew curative therapy of Bipolar Disorders, two medications may be used in the single dose or combined dosage. Lithium Carbonate, Imipramine, and the combination of both Lithium Carbonate and Imipramine medicated.

Lithium Carbonate changes the metabolism of the central nervous system of biogenic monoamines and affects multiple neurotransmission systems. Imipramine is a Tricyclic Antidepressant that enhances monoamine neurotransmission in certain of the brain region and also induces sedation.

The treatment could be in two categories: Bipolar I and Bipolar II conditions (patients). Lithium treatment prevents manic episodes reduces the risk of relapse. In bipolar status, lithium carbonate and the combination medication out work the dosage for imipramine, in preventing manic reversion and protect depression action. The combination medication with no success against lithium carbonate single dose. In bipolar II conditions, combination dosage was more successful than lithium carbonate and place be in precaution of depressive reversion. The double treatment does not affect single dosage alone. The lithium carbonate dosage had less manic episodes than other medications. Imipramine relief symptoms of psychiatry and temporary adjunctive or short-term management of a sensitive depressive episode.

Conclusion.

This condition alters persons moods and behavior and affects their lives. Test for the disease is not simple, but no tests only combine diagnosis is employed.

Mood stabilizers should be the first line treatment for bipolar depression, and in case this fails, and antidepressant medication should be in action. Mixed depressive conditions have more episodes and caution is required when antidepressant may agitate. If the risk of mood conversion may not radically occur in the current status but may lead to a lifetime risk of polarity change and mixed conditions.

Lithium (Lithobid) and imipramine (Tofranil ) and others medication are not approved for the treatment of bipolar depression. Safety of antidepressants and lithium, selected anticonvulsants and new antipsychotic agents, given in monotherapy when in controlled combinations.

Exclusion.

For good results for drug therapy, some health issue and medication should be confirmed or body conditions at the time of treatment plus drugs used before the process

Aripiprazole.

Substance abuse.

Traumatic brain injury.

Neuropsychiatric.

Brain development impairments.